Literature DB >> 21877204

Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia.

Edgar Turner Overton1, John S K Kauwe, Robert Paul, Karen Tashima, David F Tate, Pragna Patel, Charles C J Carpenter, David Patty, John T Brooks, David B Clifford.   

Abstract

HIV-associated neurocognitive disorders remain prevalent but challenging to diagnose particularly among non-demented individuals. To determine whether a brief computerized battery correlates with formal neurocognitive testing, we identified 46 HIV-infected persons who had undergone both formal neurocognitive testing and a brief computerized battery. Simple detection tests correlated best with formal neuropsychological testing. By multivariable regression model, 53% of the variance in the composite Global Deficit Score was accounted for by elements from the brief computerized tool (P < 0.01). These data confirm previous correlation data with the computerized battery. Using the five significant parameters from the regression model in a Receiver Operating Characteristic curve, 90% of persons were accurately classified as being cognitively impaired or not. The test battery requires additional evaluation, specifically for identifying persons with mild impairment, a state upon which interventions may be effective.

Entities:  

Mesh:

Year:  2011        PMID: 21877204      PMCID: PMC3594991          DOI: 10.1007/s10461-011-0033-9

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  22 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Norms for letter and category fluency: demographic corrections for age, education, and ethnicity.

Authors:  J A Gladsjo; C C Schuman; J D Evans; G M Peavy; S W Miller; R K Heaton
Journal:  Assessment       Date:  1999-06

3.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

4.  The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery.

Authors:  Lucette A J Cysique; Paul Maruff; David Darby; Bruce J Brew
Journal:  Arch Clin Neuropsychol       Date:  2005-12-15       Impact factor: 2.813

5.  The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity.

Authors:  M C Diehr; R K Heaton; W Miller; I Grant
Journal:  Assessment       Date:  1998-12

6.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

7.  The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).

Authors:  Claudia Vellozzi; John T Brooks; Timothy J Bush; Lois J Conley; Keith Henry; Charles C J Carpenter; E Turner Overton; John Hammer; Kathy Wood; Scott D Holmberg
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

8.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

9.  Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R K Heaton; R A Velin; J A McCutchan; S J Gulevich; J H Atkinson; M R Wallace; H P Godfrey; D A Kirson; I Grant
Journal:  Psychosom Med       Date:  1994 Jan-Feb       Impact factor: 4.312

10.  The trail making test, part B: cognitive flexibility or ability to maintain set?

Authors:  Kathleen Bechtold Kortte; Michael David Horner; Whitney K Windham
Journal:  Appl Neuropsychol       Date:  2002
View more
  25 in total

1.  Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.

Authors:  Angela Matinella; M Lanzafame; M A Bonometti; A Gajofatto; E Concia; S Vento; S Monaco; S Ferrari
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

2.  Identification and functional characterization of HIV-associated neurocognitive disorders with large-scale Granger causality analysis on resting-state functional MRI.

Authors:  Udaysankar Chockanathan; Adora M DSouza; Anas Z Abidin; Giovanni Schifitto; Axel Wismüller
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-02-27

3.  Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals.

Authors:  Kara R Douglas-Newman; Rachel V Smith; Mary V Spiers; Timothy Pond; Henry R Kranzler
Journal:  Addict Disord Their Treat       Date:  2017-09

4.  Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.

Authors:  Jaime H Vera; Qi Guo; James H Cole; Adriano Boasso; Louise Greathead; Peter Kelleher; Eugenii A Rabiner; Nicola Kalk; Courtney Bishop; Roger N Gunn; Paul M Matthews; Alan Winston
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

5.  Temporal processsing demands in the HIV-1 transgenic rat: Amodal gating and implications for diagnostics.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2016-12-28       Impact factor: 2.457

6.  Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.

Authors:  Nirupama Yechoor; Sheri L Towe; Kevin R Robertson; Daniel Westreich; Noeline Nakasujja; Christina S Meade
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

7.  Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Authors:  Sara Cross; Nur Önen; Amber Gase; Edgar Turner Overton; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2013-10-10       Impact factor: 4.147

Review 8.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford; Beau M Ances
Journal:  Lancet Infect Dis       Date:  2013-11       Impact factor: 25.071

9.  Prepulse inhibition in HIV-associated neurocognitive disorders.

Authors:  Arpi Minassian; Brook L Henry; Steven Paul Woods; Florin Vaida; Igor Grant; Mark A Geyer; William Perry
Journal:  J Int Neuropsychol Soc       Date:  2013-04-03       Impact factor: 2.892

10.  Physical Activity Affects Brain Integrity in HIV+ Individuals.

Authors:  Mario Ortega; Laurie M Baker; Florin Vaida; Robert Paul; Brian Basco; Beau M Ances
Journal:  J Int Neuropsychol Soc       Date:  2015-11       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.